Potential Nitric Oxide Treatment for Resistant Bacterial Infections Gets Patent, May Start Clinical
A possible inhalable treatment for antibiotic-resistant bacterial infections in people with cystic fibrosis due to Pseudomonas aeruginosa...
Cancer gene plays key role in cystic fibrosis lung infections
PTEN is best known as a tumor suppressor, a type of protein that protects cells from growing uncontrollably and becoming cancerous. But...
Why Aspiration Is a Silent, Hidden Danger for Cystic Fibrosis Patients
Dr. Gwen A. Huitt is an infectious disease doctor at National Jewish Health with a special interest in mycobacteria, bronchiectasis, and...
Protein structure could unlock new treatments for cystic fibrosis
Cystic fibrosis is a severe hereditary disease of the lung, for which there is currently no cure. The underlying cause of the disease is...
Proteostasis’ CFTR Modulators Show Potential in Improving Effectiveness of Orkambi
Clinical trials on all three Proteostasis Therapeutics’ investigational cystic fibrosis modulators — PTI-428, PTI-801, and PTI-808 — have...
Scientists Explore New Way to Generate Stem Cell-like Cells for CF Therapy
Canadian researchers developed a safer and more cost-effective method for transforming differentiated adult cells into stem-like cells, a...
Garlic Compound Could Kill Superbugs
Garlic can do more than ward off vampires. It appears an active sulphurous compound, called ajoene, in the allium can help fight...
Kalydeco Seen as Safe in Treating Young Children, Ages 1 to 2, in Phase 3 Trial, Vertex Reports
Kalydeco (ivacaftor) is safe and effective in 1- and 2-year-olds with cystic fibrosis (CF), Vertex Pharmaceuticals reported based on data...
New Simple Test Could Help Cystic Fibrosis Patients Find Best Treatment
These are nasospheroids that developed from a CF patient's nasal tissue in a dish. UNC researchers are using them to screen the...
GLPG2222 Plus Kalydeco Shows Positive Clinical Results in Phase 2 Trial, Galapagos Reports
Adding investigational CFTR corrector GLPG2222 safely improved disease parameters in cystic fibrosis (CF) patients treated with Kalydeco...
